United States Mint Begins Shipping 2025 American Women Quarters™ Honoring Dr. Vera Rubin on June 2
WASHINGTON, D.C., May 27, 2025 (GLOBE NEWSWIRE) -- The United States Mint (Mint) will begin shipping the American Women Quarters (AWQ) Program coin honoring Dr. Vera Rubin on June 2, the third in this series for 2025. The Mint facilities at Philadelphia and Denver manufacture these circulating quarters.
Dr. Vera Rubin was a pioneering astronomer whose observations of galaxy rotation provided the first persuasive evidence of dark matter. This major scientific discovery transformed our understanding of the universe.
'The third coin of the American Women Quarters Program for 2025 celebrates the life and legacy of Dr. Vera Rubin,' said Kristie McNally, the Mint's Acting Director. 'Dr. Rubin gathered crucial data to support the existence of the unseen material that binds entire galaxies together and is believed to make up more than 80 percent of the mass of the universe. The data on dark matter from dozens of galaxies that Rubin presented to the International Astronomical Union in 1985 ultimately changed scientific conceptions of the universe and opened new paths in both astronomy and physics.'
The reverse (tails) design features a profile of Dr. Vera Rubin gazing upward, smiling as she contemplates the cosmos. She is surrounded by a spiral galaxy and other celestial bodies. Inscriptions include 'DR. VERA RUBIN,' 'QUARTER DOLLAR,' 'E PLURIBUS UNUM,' and 'UNITED STATES OF AMERICA.' The additional inscription, 'DARK MATTER," the invisible mass found in our galaxy, is inscribed at the bottom of the design.
Artist Infusion Program Designer Christina Hess designed the image, which Mint Medallic Artist John P. McGraw sculpted.
'Dr. Rubin's story exemplifies strength, dedication, and determination, and it was a great honor to illustrate her portrait and legacy,' said Hess. 'By positioning her portrait off-center and toward the upper right, I aimed to move the audience's gaze upward, symbolizing exploration beyond the coin's boundaries, evoking a sense of infinite possibility and continuous motion.'
'Vera Rubin was an American astronomer and genius,' said McGraw. 'Layering her portrait with the galaxy in the background made for a fun and challenging sculpt. I feel honored that I was given the opportunity to memorialize her and her contributions to science on a coin.'
Each coin in the AWQ series features a common obverse (heads) design depicting a portrait of George Washington. This design was originally composed and sculpted by Laura Gardin Fraser as a candidate entry for the 1932 quarter, which honored the bicentennial of George Washington's birth. The inscriptions are 'LIBERTY,' 'IN GOD WE TRUST,' and '2025.'
View an image of the Dr. Vera Rubin quarter reverse here.
Each AWQ honoree is a powerful, inspiring example of the breadth, depth, and range of accomplishments, and the experiences demonstrated by these extraordinary women. Coins featuring additional honorees will continue to ship until the end of the AWQ program in 2025.
Authorized by Public Law 116-330, the American Women Quarters Program features coins with reverse (tails) designs emblematic of the accomplishments and contributions of American women. Beginning in 2022 and continuing through 2025, the Mint is issuing five quarters in each of these years. The ethnically, racially, and geographically diverse group of individuals honored through this program reflects a wide range of accomplishments and fields, including suffrage, civil rights, abolition, government, humanities, science, space, and the arts.
Numismatic Products
The AWQ program is an excellent way to remind future generations what can be accomplished with vision, determination, and a desire to improve opportunities for all. Subscribe to the program today to ensure fulfillment of your favorite product through 2025.
About the United States Mint
Congress created the United States Mint in 1792, and the Mint became part of the Department of the Treasury in 1873. As the Nation's sole manufacturer of legal tender coinage, the Mint is responsible for producing circulating coinage for the Nation to conduct its trade and commerce. The Mint also produces numismatic products, including proof, uncirculated, and commemorative coins; Congressional Gold Medals; silver and bronze medals; and silver and gold bullion coins. Its numismatic programs are self-sustaining and operate at no cost to taxpayers.
ADDITIONAL RESOURCES:
Visit https://www.usmint.gov/about for information about the United States Mint.
Visit https://www.usmint.gov/help-center/newsletters-and-alerts.html to subscribe to United States Mint electronic product notifications, news releases, public statements, and our monthly educational newsletter, Lessons That Make Cents.
Visit and subscribe to the United States Mint's YouTube channel to view videos about the United States Mint.
Follow us on Facebook, X, and Instagram.
CONTACT: Sharon McPike United States Mint 202-354-7227 sharon.mcpike@usmint.treas.gov
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Certified Tea Sommelier Teams with Tejava to Celebrate National Iced Tea Day and Share Tips with YourUpdateTV
Certified Tea Sommelier Gabrielle Jammal Shares Expert Tips for National Iced Tea Day and Why Tejava Is Her Summer Go-To NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- National Iced Tea Day is June 10, and it's the perfect time to raise a glass and toast to everyone's favorite summertime beverage. Certified Tea Sommelier Gabrielle Jammal, teamed with Tejava this week to participate in a nationwide satellite media tour to discuss National Iced Tea Day, what to look for in an iced tea, and some creative ways to enjoy Tejava this summer. When it comes to iced tea, quality ingredients and origin are key. Similar to wine, tea is deeply influenced by where and how it's grown. Tejava is a premium, unsweetened bottled tea brewed in small batches using leaves from Rainforest Alliance Certified farms in Java, Indonesia. It's crafted to preserve the natural flavor and character of the tea leaves. Tejava offers a clean, refreshing tea experience with zero sugar, zero calories, and no added preservatives, making it a convenient and healthy option for summer. Available in a variety of unsweetened flavors and bottled in both single-serve and 1-liter formats, it's ideal for serving at summer meals or sharing with guests as an elevated non-alcoholic option. While Tejava is refreshing and delicious straight from the bottle, it also invites creativity. Adding sparkling water and fresh fruit can transform it into a bubbly, tea-infused drink that's perfect for summer gatherings. Its variety of unsweetened flavors and 1-liter glass bottle also makes it a great companion at the table. In celebration of National Iced Tea Day, Tejava is offering a special promotion exclusively for residents of California. From June 7 through June 13, more than 20,000 free bottles of Tejava will be distributed through DashMart on DoorDash. Californians can participate by placing a grocery order via the DoorDash app and selecting the DashMart icon—eligible customers will receive a free bottle of Tejava with their delivery. To learn more about Tejava and where to buy it, as well as creative recipes to help you enjoy National Iced Tea Day, visit About Gabrielle JammalGabrielle Jammal is a certified tea sommelier and hospitality expert who led the tea program at the Baccarat Hotel New York. Raised in a multicultural family where tea was part of everyday tradition, she brings a personal and professional passion for tea to her work. Her expertise has been featured in Forbes, Robb Report, Bloomberg Pursuits, Food & Wine, and more. * YourUpdateTV is a property of D S Simon Media. The video included and release was part of a media tour that was produced by D S Simon Media on behalf of Tejava Dante MuccigrossoDirector of Media Integration & Client ReportingE: dantem@ 973.524.0104 A video accompanying this announcement is available at in to access your portfolio
Yahoo
29 minutes ago
- Yahoo
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or 'NewAmsterdam' or the 'Company'), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease ('CVD') with elevated low-density lipoprotein cholesterol ('LDL-C'), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will host an R&D Day event for analysts and investors on June 11, 2025 beginning at 9:00 a.m. ET in New York City. Please join members of our management team, including: Michael Davidson, M.D., Chief Executive Officer, John Kastelein, M.D., Ph.D., FESC, Founder and Chief Scientific Officer, BJ Jones, Chief Commercial Officer, Ian Somaiya, Chief Financial Officer, and Matthew Philippe, Executive Vice President. A live webcast of the R&D event will be available and those who intend to join virtually can pre-register for the webcast through the link here. The live webcast and supporting presentation materials will be available on the Events section of the Investor Relations page of the NewAmsterdam website at at the time of the live event. An archived replay will be available on the NewAmsterdam website. Please note advanced registration is required for in-person attendance. About ObicetrapibObicetrapib is a novel, oral, low-dose CETP inhibitor that NewAmsterdam is developing to overcome the limitations of current LDL-lowering treatments. In each of the Company's Phase 2 trials, ROSE2, TULIP, ROSE, and OCEAN, as well as the Company's Phase 3 BROOKLYN, BROADWAY and TANDEM trials, evaluating obicetrapib as monotherapy or combination therapy, the Company observed statistically significant LDL-lowering combined with a side effect profile similar to that of placebo. The Company commenced the Phase 3 PREVAIL CVOT in March 2022, which is designed to assess the potential of obicetrapib to reduce occurrences of MACE. The Company completed enrollment of PREVAIL in April 2024 and randomized over 9,500 patients. Commercialization rights of obicetrapib in Europe, either as a monotherapy or as part of a fixed-dose combination with ezetimibe, have been exclusively granted to the Menarini Group, an Italy-based, leading international pharmaceutical and diagnostics company. About NewAmsterdamNewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage, clinical biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple Phase 3 trials, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP inhibitor, alone or as a fixed-dose combination with ezetimibe, as LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of CVD with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated. Company ContactMatthew PhilippeP: Media ContactSpectrum Science on behalf of NewAmsterdamJaryd LeadyP: 1-856-803-7855jleady@ Investor ContactPrecision AQ on behalf of NewAmsterdamAustin MurtaghP: in to access your portfolio
Business Insider
31 minutes ago
- Business Insider
Billionaire GOP megadonor Ken Griffin is confused: Why is the US trying to bring back 'jobs that'll never pay much'?
Ken Griffin had no good answer. The billionaire founder of the $66 billion hedge fund Citadel and its sister company, market maker Citadel Securities, Griffin is a megadonor to the Republican Party and was excited for the American economy after President Donald Trump's election. Less than half a year since Trump's inauguration, Griffin said he was asked during a recent visit to China, "Why are you trying to be like China?" He said there isn't a logical reason the US would want to bring manufacturing "jobs that'll never pay much" to the country, but that seems to be the goal of the tariff policies pursued by Trump's administration. "It's one thing to make Nikes, it's another thing to make F-35 fighters," he said Thursday morning at the Forbes Iconoclast conference in Manhattan. Griffin has been critical of the administration's tariff policies in recent months, calling them a mistake that will hurt the economy and consumers. He said Thursday that they were an "anti-growth agenda," and the expected growth of the US economy has been cut in half since Trump took office. He continued his criticism of Trump, whom he voted for, focusing on the current tax bill, which was passed by the House of Representatives and is now in the Senate. Griffin said it will add "several trillions" of dollars to the deficit and lacks "tough decisions." "The United States' fiscal house is not in order," Griffin said, questioning the decision to cut taxes on small and medium-sized businesses when the deficit was rising. He said credit markets have noted the uncertainty plaguing the US thanks to the administration's policies, noting that "the risk of a US default is priced the same as Italy or Greece." "There's just no words for it," he said. If there was any optimism in his talk, it was about the resilience of American CEOs. He said hiring and capital expenditures will slow as long as there is uncertainty from Washington. Still, he was impressed with how individuals like Doug McMillon, the CEO of Walmart, explained the impact tariffs would have on the consumer. "We should not criticize CEOs for being honest," he said, adding, "shame on the administration" for scolding McMillon and other CEOs for talking about the tariffs' impact. There's still time for Trump and his team to return to pro-growth economic policies, he said, and there's no time to wait. "The United States desperately needs growth" to pay for entitlements like Social Security, he said.
